MARKET

AZN

AZN

AstraZeneca
NYSE
181.58
-3.38
-1.83%
After Hours: 180.67 -0.91 -0.50% 18:23 05/15 EDT
OPEN
183.25
PREV CLOSE
184.96
HIGH
183.44
LOW
180.55
VOLUME
1.38M
TURNOVER
--
52 WEEK HIGH
210.50
52 WEEK LOW
125.48
MARKET CAP
281.63B
P/E (TTM)
27.29
1D
5D
1M
3M
1Y
5Y
1D
Biopharmas look to China, elsewhere for partnerships, R&D
Seeking Alpha · 1d ago
AstraZeneca announces results interim analysis of Volga Phase III trial
TipRanks · 1d ago
ASTRAZENECA - IMFINZI WITH OR WITHOUT IMJUDO PLUS EV SHOWS NO NEW SAFETY SIGNALS IN VOLGA TRIAL
Reuters · 1d ago
ASTRAZENECA - IMFINZI PLUS IMJUDO AND EV SHOWS SIGNIFICANT EVENT-FREE SURVIVAL IMPROVEMENT IN VOLGA TRIAL
Reuters · 1d ago
J.P. Morgan Remains a Buy on AstraZeneca (AZN)
TipRanks · 1d ago
Buying CBRS Stock After the Cerebras IPO Is a Bet on Engineering Magic. That Same Magic Could Be the Kiss of Death.
Barchart · 1d ago
AstraZeneca Imfinzi combo improves survival in bladder cancer study
Seeking Alpha · 1d ago
AstraZeneca’s Imfinzi Combo Delivers Survival Gains in Cisplatin-Ineligible Bladder Cancer
TipRanks · 1d ago
More
About AZN
AstraZeneca PLC is a United Kingdom-based science-led biopharmaceutical company. The Company focuses on the discovery, development, and commercialization of prescription medicines. The Company operates across therapy areas, including Oncology; Cardiovascular, Renal and Metabolism (CVRM); Respiratory and Immunology (R&I); Vaccines and Immune Therapies (V&I), and Rare Disease. In the Oncology area, its key products include Tagrisso, Imfinzi, Calquence, Lynparza, and Enhertu. The key products of CVRM area include Farxiga/Forxiga, Brilinta/Brilique, Crestor, and Lokelma. In the R&I area, the key products are Symbicort, Fasenra, Breztri/Trixeo, and Tezspire. In the V&I Therapies area, the products are Beyfortus and FluMist. The products in the Rare Disease area are Ultomiris, Soliris, Strensiq, and Koselugo. It has about 191 projects in its development pipeline, including 19 new molecular entities (NMEs) in the late-stage pipeline. The Company distributes its products in over 125 countries.

Webull offers AstraZeneca PLC (US) stock information, including NYSE: AZN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AZN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading AZN stock methods without spending real money on the virtual paper trading platform.